文献速递冠心病心力衰竭与心肌病血脂与心血管预防

高敏肌钙蛋白I与冠心病事件、卒中、心衰住院及死亡的关系:ARIC研究

High-Sensitivity Troponin I and Incident Coronary Events, Stroke, Heart Failure Hospitalization, and Mortality in the ARIC Study.
PubMed 文献 · Circulation · 2019-04-29

在ARIC研究8121名54-74岁无基线心血管病的社区人群中,中位随访约15年发现,高敏肌钙蛋白I(hs-TnI)最高五分位(≥3.8 ng/L)较低五分位(≤1.3 ng/L)显著增加冠心病、缺血性卒中、动脉粥样硬化性心血管病、心衰住院、全局心血管病及全因死亡风险。hs-TnI与高敏肌钙蛋白T仅中度相关(r=0.47),两者对心血管事件预测互补;将hs-TnI加入Pooled Cohort Equation模型可改善动脉粥样硬化性心血管病、心衰和全局心血管病的风险预测。

要点

  • hs-TnI最高五分位与心衰住院风险关联最强(HR 4.20),其次为缺血性卒中(HR 2.99)。
  • hs-TnI与hs-TnT预测心血管事件互补,两者均升高者风险最高。
  • hs-TnI加入传统风险模型可改善动脉粥样硬化性心血管病、心衰和全局心血管病预测。

核心结论

  • 在无基线心血管病的社区人群中,升高的hs-TnI与全局心血管病发病率增加独立相关,且独立于传统风险因素。
  • hs-TnI与高敏肌钙蛋白T提供互补而非冗余的预测信息,两者同时升高时风险最高。
  • 将hs-TnI加入Pooled Cohort Equation模型可改善动脉粥样硬化性心血管病、心衰和全局心血管病的风险预测。

研究设计与样本

  • ARIC研究(Atherosclerosis Risk in Communities)纳入年龄54至74岁、无基线心血管病的参与者8121名。
  • 采用Cox比例风险模型分析hs-TnI与 incident 冠心病(心肌梗死和致命性冠心病)、缺血性卒中、动脉粥样硬化性心血管病(冠心病和卒中)、心衰住院、全局心血管病(动脉粥样硬化性心血管病和心衰)及全因死亡的关联。
  • 同时评估hs-TnI与高敏肌钙蛋白T对心血管事件预测的比较,并构建风险预测模型评估hs-TnI加入Pooled Cohort Equation传统风险因素后的预测改善。
  • 中位随访时间约15年。

主要发现

  • 85%的研究人群可检测到hs-TnI水平。
  • 与最低五分位(hs-TnI ≤1.3 ng/L)相比,最高五分位(hs-TnI ≥3.8 ng/L)与 incident 冠心病风险增加相关(HR 2.20;95% CI 1.64-2.95)。
  • 最高五分位hs-TnI与缺血性卒中(HR 2.99;95% CI 2.01-4.46)、动脉粥样硬化性心血管病(HR 2.36;95% CI 1.86-3.00)、心衰住院(HR 4.20;95% CI 3.28-5.37)、全局心血管病(HR 3.01;95% CI 2.50-3.63)及全因死亡(HR 1.83;95% CI 1.56-2.14)风险增加相关。
  • hs-TnI与 incident 全局心血管病的关联在白人个体中强于黑人个体,与 incident 冠心病的关联在女性中强于男性。
  • hs-TnI与高敏肌钙蛋白T仅中度相关(r=0.47),两者在预测 incident 心血管事件方面互补,两者均升高时风险最高。

临床怎么用

  • 在无心血管病的社区人群中,可考虑检测hs-TnI以识别全局心血管病、心衰住院及死亡风险较高的个体。
  • hs-TnI与hs-TnT联合检测可能提供互补的风险信息,两者均升高者风险最高。
  • 将hs-TnI加入传统风险模型(如Pooled Cohort Equation)可能改善动脉粥样硬化性心血管病、心衰和全局心血管病的风险预测。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: We assessed whether plasma troponin I measured by a high-sensitivity assay (hs-TnI) is associated with incident cardiovascular disease (CVD) and mortality in a community-based sample without prior CVD. METHODS: ARIC study (Atherosclerosis Risk in Communities) participants aged 54 to 74 years without baseline CVD were included in this study (n=8121). Cox proportional hazards models were constructed to determine associations between hs-TnI and incident coronary heart disease (CHD; myocardial infarction and fatal CHD), ischemic stroke, atherosclerotic CVD (CHD and stroke), heart failure hospitalization, global CVD (atherosclerotic CVD and heart failure), and all-cause mortality. The comparative association of hs-TnI and high-sensitivity troponin T with incident CVD events was also evaluated. Risk prediction models were constructed to assess prediction improvement when hs-TnI was added to traditional risk factors used in the Pooled Cohort Equation. RESULTS: The median follow-up period was ≈15 years. Detectable hs-TnI levels were observed in 85% of the study population. In adjusted models, in comparison to low hs-TnI (lowest quintile, hs-TnI ≤1.3 ng/L), elevated hs-TnI (highest quintile, hs-TnI ≥3.8 ng/L) was associated with greater incident CHD (hazard ratio [HR], 2.20; 95% CI, 1.64-2.95), ischemic stroke (HR, 2.99; 95% CI, 2.01-4.46), atherosclerotic CVD (HR, 2.36; 95% CI, 1.86-3.00), heart failure hospitalization (HR, 4.20; 95% CI, 3.28-5.37), global CVD (HR, 3.01; 95% CI, 2.50-3.63), and all-cause mortality (HR, 1.83; 95% CI, 1.56-2.14). hs-TnI was observed to have a stronger association with incident global CVD events in white than in black individuals and a stronger association with incident CHD in women than in men. hs-TnI and high-sensitivity troponin T were only modestly correlated ( r=0.47) and were complementary in prediction of incident CVD events, with elevation of both troponins conferring the highest risk in comparison with elevation in either one alone. The addition of hs-TnI to the Pooled Cohort Equation model improved risk prediction for atherosclerotic CVD, heart failure, and global CVD. CONCLUSIONS: Elevated hs-TnI is strongly associated with increased global CVD incidence in the general population independent of traditional risk factors. hs-TnI and high-sensitivity troponin T provide complementary rather than redundant information.

来源:Circulation,查看原文。版权归原作者所有。

引用

  1. Jia X, Sun W, Hoogeveen RC, et al. High-Sensitivity Troponin I and Incident Coronary Events, Stroke, Heart Failure Hospitalization, and Mortality in the ARIC Study. Circulation. 2019. PMID: 31030544. doi:10.1161/CIRCULATIONAHA.118.038772

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。